EUCTR2011-003248-36-CZ
Active, not recruiting
Phase 1
The clinical significance of epigenetic factors research to refine the diagnosis, estimate prognosis and risk of recurrence after curative pancreatic cancer resection.
ConditionsThe aim of the study to estimate frequence of epigenetics changes in pancreatic cancer and to assess the signidicance of apllication of the intravenous contrast agent during endosonography to better visualusation of the lesions.MedDRA version: 14.0 Level: LLT Classification code 10016335 Term: Feeling hot and cold System Organ Class: 10018065 - General disorders and administration site conditionsMedDRA version: 14.0 Level: LLT Classification code 10037872 Term: Rash NOS System Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 14.0 Level: LLT Classification code 10032168 Term: Other insomnia System Organ Class: 10037175 - Psychiatric disordersMedDRA version: 14.0 Level: LLT Classification code 10008481 Term: Chest pain - cardiac System Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.0 Level: LLT Classification code 10064907 Term: Functional abdominal pain System Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 14.0 Level: LLT Classification code 10048324 Term: Dizziness aggravated System Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.0 Level: LLT Classification code 10033777 Term: Paraesthesia distal System Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.0Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
DrugsSonoVue
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- The aim of the study to estimate frequence of epigenetics changes in pancreatic cancer and to assess the signidicance of apllication of the intravenous contrast agent during endosonography to better visualusation of the lesions.
- Sponsor
- Central Military Hospital
- Enrollment
- 120
- Status
- Active, not recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients with chronic pancreatitis
- •patients with pancreatic focal mass
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 60
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range 60
Exclusion Criteria
- •age under 18 years
- •pregnancy and lactation
- •disagreement with participation in the study
- •chronic pancreatitis without mass
- •patients with severe heart and pulmonary failure
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
The role of environmental factors on genetic predisposition of neonatal sepsis susceptibilityCTRI/2012/09/002986I256
Completed
Not Applicable
Epigenetics and Psychoneurologic Symptoms in Women With Breast CancerBreast CancerNCT01411943Virginia Commonwealth University75
Completed
Not Applicable
DNA Methylation Analysis in Acute Coronary Syndrome and Atrial Fibrillation: DIANA Clinical TrialCoronary Artery DiseaseAcute Coronary SyndromeAtrial FibrillationNCT04371809University of Campania "Luigi Vanvitelli"100
Recruiting
Not Applicable
Fecal Microbiota Transfer Therapy for AutismCTRI/2022/02/040457Providence Microbiome Research Center Private Limited
Active, not recruiting
Not Applicable
Comprehensive Study of Post-surgical Pain After Pectus or Spine SurgeryPain, PostoperativeExcavatum, PectusScoliosis IdiopathicNCT04031716Children's Hospital Medical Center, Cincinnati600